Intervention Maps · Hyperlipidemia · Plant sterols and stanols
Plant sterols and stanols
This page is about plant sterols and stanols as a food tool for lowering LDL. They can move the lipid panel. That's not the same as proven protection from heart attack or stroke, and it's not the same as eating a full Portfolio-style pattern.
Bottom line
Plant sterols and stanols stay on the map as an LDL food tool. Across a large dose-response base they lower LDL by about 6–12% over roughly 0.6–3.3 g per day, approaching about 12% near 3 g per day, with similar sterol and stanol patterns. That is a lipid-panel decision, not proven event prevention, not Portfolio completion, and not the popular-supplements shelf.
What it is
Plant sterols and stanols are compounds added to foods (such as some spreads and yogurts) or taken as supplements to lower LDL cholesterol. Sterols and stanols behave similarly enough in the dose-response evidence used here that this page treats them as one food-tool family.
What taking part usually involves
Getting a studied daily amount through fortified foods, a supplement, or both, usually every day for weeks before judging the lipid response. Product labels vary. This page does not pick a brand.
What it is commonly confused with
“Sterols prevent heart attacks.” “Buying a sterol spread completes the Portfolio diet.” “This belongs with red yeast rice and other cholesterol supplements as the same kind of claim.” “If LDL falls, events are proven.”
What the evidence shows
Across a large dose-response evidence base (on the order of 124 studies in the package used here), plant sterols and stanols lower LDL by about 6–12% across roughly 0.6–3.3 g per day, approaching about 12% near 3 g per day. Sterol and stanol dose-responses look comparable.
There is not a cardiovascular-outcome package that turns that LDL change into proven event prevention. Guideline material used here concurs that this remains a lipid-panel tool.
This is not Portfolio completion. Portfolio is a multi-component pattern on the eating-patterns page. It is also not the popular-supplements shelf.
Who was studied, expectations, and limits
Population and context studied: adults in numerous short- to medium-term lipid trials of sterol/stanol foods and supplements.
That is the research setting, not a product endorsement.
Realistic expectation: a studied daily amount can lower LDL in a dose-responsive way. Limits: not hard-event proof; not Portfolio by itself; not a substitute for indicated medicines when medicines are indicated; not a hero supplement story.
Evidence consulted Open sources
Key sources used to prepare this answer. This is not a citation for every sentence.
← Back to Hyperlipidemia · find this again later from “What are you trying to figure out?”